Celyad Oncology SA

EBR:CYAD.BR

0.5 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 7.00412.44530.01817.23439.33840.54223.25348.357100.17527.63319.0581.6450
Short Term Investments 000009.19710.65334.237.3382.671300
Cash and Short Term Investments 7.00412.44530.01817.23439.33849.73933.90682.587107.51330.30422.0581.6450
Net Receivables 0.381.2592.340.9072.7020.2770.0810.0540.0621.7170.1490.4431.013
Inventory -0.077001.5630000.6420.1990.9130-1.6450
Other Current Assets 3.8141.1211.9342.0760.7961.6762.5592.7260.5442.60.1230.2491.802
Total Current Assets 11.12114.82534.29219.70542.83651.69236.39485.367109.41932.93522.6022.1923.469
Non-Current Assets:
Property, Plant & Equipment, Net 1.830.3093.2484.1195.0613.0143.293.5631.1360.5980.2430.3830.355
Goodwill 0.34200.8830.8830.8830.8830.9141.041.0030000
Intangible Assets 0.0480.86435.28535.28835.31635.28135.59448.52647.78610.2669.400
Goodwill and Intangible Assets 0.390.86436.16836.17136.19936.16436.50849.56648.78910.2669.411.022.87
Long Term Investments 002.2095.7965.4833.2140.2730.3110.1810.06800.1510
Tax Assets 00-2.209-5.796-5.483-3.214-0.273-0.311-0.18100-0.1510
Other Non-Current Assets 2.9413.7186.2356.0895.743.4291.4340.3110.180.1090.140.1510.183
Total Non-Current Assets 5.1614.89145.65146.3794742.60741.23253.4450.10511.0419.78311.5543.408
Total Assets 16.28219.71679.94366.08489.83694.29977.626138.805159.52543.97632.38613.7466.877
Liabilities & Equity:
Current Liabilities:
Account Payables 1.2434.7526.6114.7366.9695.9164.88.0988.5764.0422.1691.771.086
Short Term Debt 0.1560.1370.9021.1131.3590.7650.6360.5610.2480.1340.0790.4080
Tax Payables 000001.3510.9470000.1030.0560.061
Deferred Revenue 01.3261.4582.2090.3460.2760.2261.1080.8980.7770.4280.6450
Other Current Liabilities 1.5335.5376.3145.9853.5941.3391.3361.5082.6661.8770.6090.5984.774
Total Current Liabilities 2.93210.42613.82711.83411.9229.6477.94511.27511.496.0533.3892.7315.921
Non-Current Liabilities:
Long Term Debt 0.9020.118-13.002-13.6153.0040.8810.8080.9170.4270.2790.0270.9210.116
Deferred Revenue Non-Current 04.5845.8514.224.1392.8641.5447.3310.48410.77812.07200
Deferred Tax Liabilities Non-Current 0014.73216.1403.2120.2040.2040.1210-12.07200
Other Non-Current Liabilities 6.1440.2710.1640.37125.15222.10621.13435.52536.01410.9612.07221.7510
Total Non-Current Liabilities 7.0464.97322.47723.25632.29529.06322.14636.64636.56211.23912.09912.3280.116
Total Liabilities 9.97815.39936.30435.0944.21738.7130.09147.92148.05217.29215.48815.0586.037
Equity:
Preferred Stock 0000000000000
Common Stock 32.94978.58578.58548.51348.51341.55334.33732.57132.57124.61522.1389.9759.975
Retained Earnings -358.372-349.947-308.997-91.826-74.424-217.778-180.421-124.026-100.313-71.215-36.388-11.287-9.134
Accumulated Other Comprehensive Income/Loss 331.727269.362267.73430.95828.18125.66723.32224.32921.20519.982-1.87200
Other Total Stockholders Equity 06.3176.317-147.86443.349206.149170.297158.01158.0153.30230.474-1.954-0
Total Shareholders Equity 6.3044.31743.63930.99445.61955.59147.53590.884111.47326.68416.898-1.3120.84
Total Equity 6.3044.31743.63930.99445.61955.59147.53590.884111.47326.68416.898-1.3120.84
Total Liabilities & Shareholders Equity 16.28219.71679.94366.08489.83694.30177.626138.805159.52543.97632.38613.7466.877